Methylomic profiling of ovarian cancer-initiating cells identifies DNA methylation as a prognostic biomarker

H. Lai, Y. Liao, R. Huang

Research output: Contribution to journalArticle

Abstract

Epigenetic changes of ovarian cancer-initiating cells remain unexplored. In this study, we aimed to discover novel DNA methylation in ovarian cancer initiation cells and tested its potential as a prognostic biomarker.
Original languageTraditional Chinese
Pages (from-to)e133-e134
JournalGynecologic Oncology
Volume130
Issue number1
DOIs
Publication statusPublished - Jul 2013
Externally publishedYes

Cite this

Methylomic profiling of ovarian cancer-initiating cells identifies DNA methylation as a prognostic biomarker. / Lai, H.; Liao, Y.; Huang, R.

In: Gynecologic Oncology, Vol. 130, No. 1, 07.2013, p. e133-e134.

Research output: Contribution to journalArticle

@article{aef329ed681945aba8847f56b1993630,
title = "Methylomic profiling of ovarian cancer-initiating cells identifies DNA methylation as a prognostic biomarker",
abstract = "Epigenetic changes of ovarian cancer-initiating cells remain unexplored. In this study, we aimed to discover novel DNA methylation in ovarian cancer initiation cells and tested its potential as a prognostic biomarker.",
author = "H. Lai and Y. Liao and R. Huang",
note = "doi: 10.1016/j.ygyno.2013.04.381",
year = "2013",
month = "7",
doi = "10.1016/j.ygyno.2013.04.381",
language = "繁體中文",
volume = "130",
pages = "e133--e134",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Methylomic profiling of ovarian cancer-initiating cells identifies DNA methylation as a prognostic biomarker

AU - Lai, H.

AU - Liao, Y.

AU - Huang, R.

N1 - doi: 10.1016/j.ygyno.2013.04.381

PY - 2013/7

Y1 - 2013/7

N2 - Epigenetic changes of ovarian cancer-initiating cells remain unexplored. In this study, we aimed to discover novel DNA methylation in ovarian cancer initiation cells and tested its potential as a prognostic biomarker.

AB - Epigenetic changes of ovarian cancer-initiating cells remain unexplored. In this study, we aimed to discover novel DNA methylation in ovarian cancer initiation cells and tested its potential as a prognostic biomarker.

U2 - 10.1016/j.ygyno.2013.04.381

DO - 10.1016/j.ygyno.2013.04.381

M3 - 文章

VL - 130

SP - e133-e134

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -